[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361760-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361760-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","loss-of-tnfrsf21-induces-cisplatin-sensitivity-in-lung-adenocarcinoma-article","Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma - Article","","Background: Despite many therapeutic targets identified in lung cancer, meaningful efficacy remains limited. TNFRSF21 is implicated in multiple cancers, but its role in lung adenocarcinoma (LUAD) is unclear. Methods: Prognostic relevance was evaluated using GEPIA and Kaplan–Meier Plotter. Cellular viability, TNFRSF21 expression, tumor sphere growth, and ROS levels (MitoSOX) were analyzed. Results: TNFRSF21 increased in LUAD and in cisplatin-resistant cells, while its loss suppressed LUAD growth. Mechanistically, TNFRSF21 affected proliferation, DDP resistance, and CSC-like features via ROS modulation through CD44/CD133. Conclusions: TNFRSF21 may be a novel chemotherapy target to eradicate lung CSCs.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/loss-of-tnfrsf21-induces-cisplatin-sensitivity-in-lung-adenocarcinoma-article/361760/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/loss-of-tnfrsf21-induces-cisplatin-sensitivity-in-lung-adenocarcinoma-article/361760.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was TNFRSF21 expression evaluated and linked to prognosis in lung cancer?","Question",{"text":63,"@type":64},"The study used GEPIA and Kaplan–Meier Plotter databases to assess the prognostic value of TNFRSF21 expression and its correlation with patient outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What experimental assays were used to assess LUAD cell behavior and treatment sensitivity?",{"text":68,"@type":64},"Cell viability was measured by CCK8, tumor sphere growth by tumor sphere formation assays, and cisplatin sensitivity through observed effects in DDP-resistant LUAD cells after TNFRSF21 modulation.",{"name":70,"@type":61,"acceptedAnswer":71},"How does TNFRSF21 loss influence ROS and cancer stem cell-like characteristics?",{"text":72,"@type":64},"Loss of TNFRSF21 significantly inhibited LUAD growth and was associated with increased ROS. The inhibitory effects on lung CSCs were linked to ROS changes and involved modulation of CD44 and CD133.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361760,1790870818,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","ONCOLOGY RESEARCH 2025 33(3): 653-663 ARTICLE  \nLoss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma  \nDAIEN ZHOU 1,\\#; HAOYANG YUAN2,\\#; YIWEI HU3; CHUXU WANG 1; SA GE 1; KOUFENG SHAO4; HONGYING WANG 1; XIAOFENG TIAN 1,*; HAIBO HU 1,*  \n1 Department of Thoracic Surgery, The Afﬁliated Huai’an Hospital of Xuzhou Medical University, The Second People’s Hospital of Huai’an, Huai’an, 223001, China  \n2 Medical Faculty, Kunming University of Science and Technology, Kunming, 650000, China  \n3 The First School of Clinical Medicine, Nanjing Medical University, Nanjing, 210000, China  \n4 Department of Oncology, Huai’an Chuzhou Hospital of Traditional Chinese Medicine, Zhongda Hospital Group Hospital Afﬁliated to Southeast University, Huai’an, 223001, China  \nKey words: TNFRSF21, Lung cancer, Cancer stem cells (CSCs), Cisplatin sensitivity  \nAbstract: Background: Despite the identiﬁcation of numerous therapeutic targets in lung cancer, achieving signiﬁcant efﬁcacy has been challenging. TNFRSF21 plays an important role in various cancers. We investigated the function of TNFRSF21 in lung adenocarcinoma (LUAD). Methods: The prognostic value of TNFRSF21 expression in lung cancer was evaluated by the GEPIA and Kaplan-Meier Plotter databases. Lung cancer cell viability was assessed by the CCK8 assay. TNFRSF21 expression patterns in lung cancer tissues and cells were examined using RT-PCR assay. Tumor sphere growth was evaluated through tumor sphere formation assays. MtROS contents in lung cancer cells were observed through MitoSOX ﬂuorescent assays. Result: TNFRSF21 was up-regulated in LUAD patients. TNFRSF21 induction was particularly notable in LUAD, especially in cancerous cells (A549, H1299, H460, and SPC-A1), compared to BEAS-2B cells. Additionally, TNFRSF21 was increased in cisplatin (DDP)-resistant LUAD cells. Loss of TNFRSF21 signiﬁcantly inhibited LUAD cell growth. It was observed that forced expression of TNFRSF21 contributed to tumor cell proliferation and DDP resistance. The production of ROS was found to participate in the inhibitory effects on lung cancer stem cells (CSCs), with decreased TNFRSF21 restraining ROS contents. Collectively, these ﬁndings reveal that the downregulation of TNFRSF21 promotes ROS contents to restrain the lung CSC-like characteristics via modulation of CD44 and CD133 . Conclusions: In conclusion, TNFRSF21 may act as a novel target  \nfor lung cancer chemotherapy, particularly for eradicating lung CSCs.  \nIntroduction  \nLung cancer is classiﬁed into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) [1,2] . Recently, there has been a notable increase in LUAD cases, accompanied by consistently poor patient survival rates [3] . Recurrence and metastasis, especially post-surgical removal, stand as the primary reasons for the high prevalence of LUAD [4] . For many years, DDP has been used as chemotherapy across various cancers, including LUAD.  \n*Address correspondence to: Xiaofeng Tian, [txf-1700@163.com](txf-1700@163.com); Haibo Hu, [dr_huhaibo@aliyun.com](dr_huhaibo@aliyun.com)  \n\\#These authors contributed equally  \nReceived: 30 January 2024; Accepted: 07 June 2024;  \nPublished: 28 February 2025  \nHowever, while some individuals may not react to DDP, others, despite initially being responsive, may eventually develop resistance [5] . Cancer stem cells (CSCs) are the key drivers of tumor recurrence [6] . The progression and recurrence of various cancers, including LUAD, are signiﬁcantly inﬂuenced by CSCs [7] .  \nRecent studies increasingly indicate that CSCs share characteristics with stem cells [8,9] . Additionally, speciﬁc surface markers (Nanog, Oct4, Sox2, CD44, and CD133) are expressed by lung CSCs, identiﬁed in NSCLC cell lines and patients. Several marker genes including CD133, CD44, and CD90 are associated with CSCs in lung cancer [10] . CSCssigniﬁcantly inﬂuence the progression and recurrence of various cancers, including LUAD [11] . Lung CSCs are isolated from NSCL","cbCaiq55dybyR6qw","https://ap.wps.com/l/cbCaiq55dybyR6qw","pdf",17492148,11,"English","# Introduction\n# Materials and Methods\n## Ethical approval\n## GEPIA and Kaplan-Meier Plotter database\n## Cell culture","[{\"question\":\"How was TNFRSF21 expression evaluated and linked to prognosis in lung cancer?\",\"answer\":\"The study used GEPIA and Kaplan–Meier Plotter databases to assess the prognostic value of TNFRSF21 expression and its correlation with patient outcomes.\"},{\"question\":\"What experimental assays were used to assess LUAD cell behavior and treatment sensitivity?\",\"answer\":\"Cell viability was measured by CCK8, tumor sphere growth by tumor sphere formation assays, and cisplatin sensitivity through observed effects in DDP-resistant LUAD cells after TNFRSF21 modulation.\"},{\"question\":\"How does TNFRSF21 loss influence ROS and cancer stem cell-like characteristics?\",\"answer\":\"Loss of TNFRSF21 significantly inhibited LUAD growth and was associated with increased ROS. The inhibitory effects on lung CSCs were linked to ROS changes and involved modulation of CD44 and CD133.\"}]","Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma - Article | PDF",1790145528,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff94219c30cb955a89030baeaa2f349c.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be0beed094257ecc12642d726758a5cc.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09dda24cc7dba6e3a00e41ed8acf2d05.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ce59e568aed5b308c0fbb7e6c12d6c8.webp",980,1385]